Advantage 80 Spot-on solution for Cats

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

Imidacloprid

זמין מ:

Elanco GmbH

קוד ATC:

QP53AX17

INN (שם בינלאומי):

Imidacloprid

כמות:

80 mg/pipette

טופס פרצבטיות:

Spot-on solution

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

איזור תרפויטי:

imidacloprid

מצב אישור:

Authorised

תאריך אישור:

2001-02-23

מאפייני מוצר

Health Products Regulatory Authority
20 October 2021
CRN00CCWH
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Advantage 80 Spot-on solution for Cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 0.8 ml contains:
​
ACTIVE SUBSTANCE:
​
​
Imidacloprid
​
80 mg
​
​
​
EXCIPIENT(S):
​
​
Butylhydroxytoluene (E 321)
0.8 mg
​
Benzyl alcohol (E 1519)
​
665.6 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear yellow to slightly brownish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of flea infestations on cats of 4 kg
body weight and greater.
For cats of less than 4 kg body weight use Advantage 40 for Cats.
One treatment prevents further flea infestation for three to four
weeks.
The product can be used as part of a treatment strategy for the
control of Flea Allergy Dermatitis (FAD) where this has been
previously diagnosed by a veterinary surgeon.
4.3 CONTRAINDICATIONS
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
This product is for topical use and should not be administered orally.
Care should be taken to avoid the contents of the pipette coming into
contact with the eyes or mouth of the recipient animal.
Do not allow recently treated animals to groom each other.
Any collar should be removed prior to application of the product.
Prior to re-fitting the collar, the treated area should be
visually assessed to ensure it is dry.
Health Products Regulatory Authority
20 October 2021
CRN00CCWH
Page 2 of 5
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS:
People with known hypersensitivity to imidacloprid should avoid
contact with t